Three popular GLP-1 receptor agonists carried similar risks for serious gastrointestinal (GI) events among adults with type 2 ...

SGLT2 inhibitors represent one of the most remarkable therapeutic developments in heart failure care, transitioning from ...

Hospitalized patients with diabetes require specialized management to reduce readmission rates and complications. Newer ...

Patients with asthma and T2 diabetes using SGLT2 inhibitors have a significantly decreased mortality risk within 30 days of an asthma exacerbation.

For patients with diabetes and early-stage pulmonary malignancies, administration of a sodium-glucose cotransporter 2 ...

Sean Virani, MD, lead author of the new guidelines and president of the CCS, explained that the guidelines use the term ...

A type 2 diabetes medication may lower the risk of autoimmune rheumatic diseases like rheumatoid arthritis by 11%, unlike ...

Real-world data reinforce SGLT2 inhibitors as first-line therapy for frail, older adults with heart failure with preserved ejection fraction.

Daewoong Pharmaceutical announced on October 30 that it has applied to the Animal and Plant Quarantine Agency for product approval of 'EnbloPet' ...

GLP-1s may confer greater protection from major adverse cardiovascular events compared with sulfonylureas, ...

Daewoong Pharmaceutical said Thursday it has applied for approval from Korea’s Animal and Plant Quarantine Agency for EnvloPet, a pet diabetes drug adapted from ...